Product image of Lacosmaid Mylan (Lacosamide) supplied by GNH India

Lacosmaid Mylan

Active Ingredient:
Lacosamide
Origin:
EU

Lacosmaid Mylan (Lacosamide)

Lacosamide, the active ingredient in Lacosmaid Mylan, is a sodium channel blocker presented as an oral dosage form for oral use. It is used to treat partial‑onset seizures in patients with epilepsy.

GNH India supplies Lacosmaid Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Mylan Germany Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lacosmaid Mylan is an antiepileptic drug that modulates neuronal excitability in seizure disorders.
  • Partial‑onset seizures: reduces seizure frequency as adjunctive therapy in patients with epilepsy.
  • Epilepsy (adjunctive therapy): improves overall seizure control when added to existing antiepileptic regimens.
  • Focal seizures: provides targeted seizure suppression for focal onset seizure types.

How It Works

  • Lacosamide selectively enhances the slow inactivation of voltage‑gated sodium channels in neuronal membranes. By stabilizing the inactive state of these channels, it diminishes repetitive neuronal firing and reduces hyperexcitability that underlies seizure activity, without significantly affecting normal neuronal conduction.

Side Effects

Lacosmaid Mylan may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects

  • Dizziness
  • Fatigue
  • Nausea
  • Headache
  • Diplopia (double vision)
  • Somnolence

Serious or Rare Side Effects

  • Suicidal thoughts or behavior
  • Severe skin reactions such as Stevens‑Johnson syndrome
  • Cardiac arrhythmias (e.g., PR interval prolongation)
  • Severe hypersensitivity reactions
  • Hepatic dysfunction
  • Blood dyscrasias (e.g., agranulocytosis)

Precautions & Warnings

When prescribing Lacosmaid Mylan, clinicians should consider several safety aspects.

  • Pregnancy (Category C): weigh potential benefits against fetal risks and discuss with the patient.
  • Renal impairment: assess renal function and adjust dosage if necessary.
  • Hepatic impairment: monitor liver enzymes and consider dose modification.
  • Concomitant CNS depressants: monitor for enhanced sedation or respiratory depression.
  • Driving and operating machinery: advise patients about possible dizziness or visual disturbances.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Lacosmaid Mylan can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin) may reduce lacosamide levels.
  • Co‑administration with other sodium channel blockers may increase central nervous system depression.
  • Alcohol: concurrent use can enhance sedation and dizziness.

Moderate Interactions (Monitor Closely)

  • CYP2C19 inhibitors (e.g., fluconazole) may increase lacosamide exposure.
  • Hormonal contraceptives: efficacy may be reduced; consider alternative contraception.
  • Antacids: may affect absorption; separate dosing by at least 2 hours.
  • Diuretics: monitor electrolyte balance, especially potassium levels.

Frequently Asked Questions

Lacosmaid Mylan contains lacosamide, an antiepileptic medication indicated for the treatment of partial‑onset seizures in patients with epilepsy. It is used as an adjunctive therapy to improve seizure control when added to existing antiepileptic regimens.

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neurons. This stabilizes the inactive state of the channels, reducing repetitive neuronal firing and decreasing the hyperexcitability that leads to seizure activity.

The appropriate dose of Lacosmaid Mylan is determined by the prescribing healthcare professional based on the patient’s clinical condition, response, and any relevant renal or hepatic considerations. Patients should follow the prescriber’s instructions exactly.

Lacosmaid Mylan is classified as Pregnancy Category C, meaning risk cannot be ruled out. It should only be used if the potential benefit justifies the potential risk to the fetus. Limited data are available for breastfeeding; a risk‑benefit assessment should be performed by the prescriber.

To order Lacosmaid Mylan, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lacosamide differs from many traditional antiepileptics by selectively enhancing slow inactivation of sodium channels, offering a distinct mechanism of action. Compared with drugs like carbamazepine or phenytoin, it may have a lower risk of drug‑induced hyponatremia but shares potential CNS‑related side effects.

Lacosmaid Mylan should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency.

Lacosmaid Mylan is taken orally, usually as a tablet, with or without food. The exact dosing schedule and whether it should be taken with meals are determined by the prescriber based on individual patient needs.

Serious risks include the potential for suicidal thoughts or behavior, severe skin reactions such as Stevens‑Johnson syndrome, cardiac conduction abnormalities, and rare cases of hepatic dysfunction or blood dyscrasias. Patients should be monitored closely for any of these events.

Lacosmaid Mylan is contraindicated in patients with known hypersensitivity to lacosamide or any of the tablet’s excipients. Caution is also advised for individuals with significant cardiac conduction disorders, severe hepatic impairment, or those taking interacting medications that could lead to dangerous plasma levels.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lacosamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT